Moreover, significant differences in sex ratio (33 vs. 69% of men), median PRL levels (818 vs. 4316 μg/L) and the maximal craniocaudal tumour diameter (18 ± 1 vs. 29 ± 6 mm) were observed between DA-sensitive and DA-resistant patients in this study [16]. This evidence concerns the gene PRL and neoplasm.